Insight Guide

Q&A: Effective Drug Product Process Development

Format: PDF file | Document type: Insight Guide | Promoted Content

This content is provided by Catalent, and any views and opinions expressed do not necessarily reflect those of

Q&A: Effective Drug Product Process Development

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the difference between innovator and biosimilar drug product process development, and what to expect from the development and manufacturing partner during the drug product process development phase.

Latest content from Catalent

Related resources from Catalent

Show more

Supplier info centre